Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea
· Delayed Price · Currency is KRW
3,625.00
-345.00 (-8.69%)
At close: Mar 9, 2026
Vivozon Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 179,617 | 339,731 | 144,635 | 149,085 | 186,048 | 296,774 | |
| Market Cap Growth | -60.20% | 134.89% | -2.99% | -19.87% | -37.31% | 18.74% | |
| Enterprise Value | 213,576 | 367,642 | 174,909 | 188,576 | 192,882 | 339,521 | |
| Last Close Price | 3625.00 | 6469.68 | 2821.08 | 2995.05 | 5148.47 | 9920.80 | |
| PS Ratio | 2.71 | 3.88 | 2.03 | 2.89 | 3.23 | 6.81 | |
| PB Ratio | 2.05 | 3.19 | 1.39 | 1.44 | 2.15 | 2.66 | |
| P/TBV Ratio | 2.14 | 3.32 | 1.46 | 1.52 | 2.43 | 4.76 | |
| P/FCF Ratio | - | - | - | - | - | 79.03 | |
| P/OCF Ratio | - | 59.28 | 48.35 | - | - | 64.17 | |
| EV/Sales Ratio | 3.22 | 4.20 | 2.45 | 3.66 | 3.35 | 7.79 | |
| EV/EBITDA Ratio | - | 208.45 | 22.04 | - | - | - | |
| EV/EBIT Ratio | - | - | 37.14 | - | - | - | |
| EV/FCF Ratio | -25.78 | - | - | - | - | 90.41 | |
| Debt / Equity Ratio | 0.45 | 0.34 | 0.40 | 0.58 | 0.97 | 0.97 | |
| Debt / EBITDA Ratio | - | 20.70 | 5.24 | - | - | - | |
| Debt / FCF Ratio | - | - | - | - | - | 28.87 | |
| Net Debt / Equity Ratio | 0.39 | 0.25 | 0.23 | 0.33 | 0.23 | 0.16 | |
| Net Debt / EBITDA Ratio | -2.18 | 15.03 | 3.01 | -5.50 | -1.43 | -3.03 | |
| Net Debt / FCF Ratio | -4.10 | -9.75 | -15.60 | -3.45 | -0.73 | 4.73 | |
| Asset Turnover | 0.38 | 0.49 | 0.40 | 0.27 | 0.26 | 0.21 | |
| Inventory Turnover | 1.97 | 2.59 | 3.31 | 2.21 | 2.62 | 4.67 | |
| Quick Ratio | 0.08 | 0.14 | 0.27 | 0.45 | 0.87 | 0.92 | |
| Current Ratio | 0.49 | 0.62 | 0.70 | 0.60 | 1.08 | 1.06 | |
| Return on Equity (ROE) | -29.63% | -10.13% | -2.13% | -28.26% | -71.69% | -39.98% | |
| Return on Assets (ROA) | -7.08% | -0.63% | 1.63% | -3.21% | -5.54% | -2.43% | |
| Return on Capital Employed (ROCE) | -19.20% | -1.60% | 4.30% | -9.10% | -18.60% | -5.90% | |
| Earnings Yield | -15.79% | -2.94% | -2.32% | -26.77% | -37.33% | -14.74% | |
| FCF Yield | -4.61% | -0.80% | -1.06% | -6.58% | -14.84% | 1.26% | |
| Buyback Yield / Dilution | -7.35% | -0.06% | -9.69% | -33.41% | -24.52% | -24.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.